The Minister of Energy and Natural Resources, the Honourable Jonathan Wilkinson, will hold a media callback (audio-only) to wrap up his visit to Washington, D.C.
the Honourable Jonathan Wilkinson, Canada’s Minister of Energy and Natural Resources, announced an investment of more than $900,000 to Integrity Reforestation for a major reforestation project that will help to restore wildfire-impacted land and caribou habitat in Ontario’s Ogoki Forest.
| Women and Gender Equality Canada
| backgrounders
Through the Women’s Capacity Fund, Women and Gender Equality Canada will provide funding to 170 women’s and Indigenous women’s organizations to strengthen their capacity and advance gender equality.
| Women and Gender Equality Canada
| news releases
Today, the Honourable Marci Ien, Minister for Women and Gender Equality and Youth, announced up to $40 million for 170 women’s and Indigenous women’s organizations.
| Environment and Climate Change Canada
| news releases
Today, the Government of Canada published its first publicly available annual global mean temperature forecast, predicting that 2025 will be warmer than every year on record prior to 2023.
| Environment and Climate Change Canada
| news releases
Today, the Honourable Steven Guilbeault, Minister of Environment and Climate Change, announced that the Government of Canada has designated Country Island, Isle Haute, and St. Paul Island as Canada’s newest National Wildlife Areas.
Today, the Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $32 million over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable John Dornan, New Brunswick’s Minister of Health, announced a bilateral agreement investing over $32 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.